Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Radiation Therapy
100%
Intensity Modulated Radiation Therapy
99%
Non Small Cell Lung Cancer
85%
Neoplasm
67%
Lung
59%
Overall Survival
49%
Chemoradiotherapy
48%
Neck
42%
Chemotherapy
41%
Diseases
39%
Immune Checkpoint Inhibitor
34%
Malignant Neoplasm
34%
Pneumonectomy
33%
Lung Cancer
30%
Head and Neck Cancer
29%
Progression Free Survival
29%
Mesothelioma
28%
Drug Megadose
27%
Lung Tumor
27%
Small Cell Lung Cancer
26%
Pleura Mesothelioma
21%
Dose Calculation
21%
Isocenter
20%
Oncology
19%
Stereotactic Body Radiation Therapy
19%
Treatment Planning
17%
Dose Distribution
16%
Non-Small Cell Lung Cancer
15%
Contralateral
15%
Positron Emission Tomography-Computed Tomography
15%
Paclitaxel
14%
Median Follow Up
14%
Carboplatin
13%
Arm
13%
Radiation Therapy Planning
13%
Breast Cancer
13%
Stereotactic Radiosurgery
13%
Surgical Mortality
13%
Lung Transplantation
13%
Brachytherapy
13%
Continuous Positive Airway Pressure
13%
Positron Emission Tomography
12%
Breathing
12%
Hazard Ratio
11%
Cancer Cell
11%
Lymph Node
10%
Neoadjuvant Therapy
10%
Squamous Cell
10%
Proton Therapy
10%
Polyethylene Terephthalate
10%
Keyphrases
Radiotherapy
60%
Non-small Cell Lung Cancer (NSCLC)
52%
Head-and-neck
41%
Intensity-modulated Radiotherapy
40%
Overall Survival
40%
4DCT
35%
Head-and-neck Cancer
35%
Immune Checkpoint Inhibitors
35%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
29%
Mesothelioma
29%
Progression-free Survival
25%
Radiation Dose
23%
Intensity-modulated Radiation Therapy
23%
Chemoradiotherapy
22%
Lung
22%
Chemotherapy
21%
Malignant Pleural Mesothelioma
20%
High Dose
20%
NRG Oncology
19%
Chemoradiation
19%
Tumor Volume
19%
Isocenter
19%
Extrapleural Pneumonectomy
18%
Tumor
17%
Lung Tumor
16%
Lung Cancer
16%
Pneumonectomy
16%
Definitive Chemoradiotherapy (dCRT)
16%
Cancer Institute
16%
Target Motion
16%
Dose Volume
15%
Phase I Study
15%
Portal Image
15%
Concurrent Chemoradiotherapy
14%
Three-dimensional Conformal Radiotherapy
13%
Distant Failure
13%
Portal Imaging
13%
Pneumonitis
13%
Cancer Center
13%
Concomitant Boost
13%
Surgical Mortality
13%
Surgical Complexity
13%
Lung Transplantation
13%
Dose-volume Effects
13%
Continuous Positive Airway Pressure
13%
Motion Evaluation
13%
Radiation Treatment Planning
13%
Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer (ALK-positive NSCLC)
13%
Stereotactic Radiosurgery
13%
Endobronchial Brachytherapy
13%